Special Populations

From violence risk assessment in emergency departments to connections between bipolar disorder and substance use disorders, here are highlights from the week in Psychiatric Times.

How can we ensure that diversity, equity, inclusion, and access are truly achieved in clinical trials industry-wide?

The presentation of schizophrenia differs significantly between men and women. Here's what you need to know.

What is new in research on psychiatric care for Latinx patient populations?

September 15 to October 15 is Hispanic Heritage Month. To celebrate, here’s a look at some recent coverage in Psychiatric Times® on how clinicians can improve psychiatric care for Latinx patients.

From cannabis use disorder and schizophrenia to social media use and youth mental health, here are highlights from the week in Psychiatric Times.

What is new in research on attention-deficit/hyperactivity disorder?

As we commemorate the landmark March on Washington, parallels are drawn between Dr Martin Luther King Jr's dreams of equality and the goals of social psychiatry, highlighting the need to address social determinants of mental health.

From TMS as a treatment for long COVID to an update on 988 and crisis care, here are highlights from the week in Psychiatric Times.

According to the National Community Pharmacists Association, 97% of independent pharmacy owners reported shortages of Adderall in early 2023. As these shortages continue, here's how you can best support your patients with ADHD.

From overutilization of emergency departments to reversible clomiphene-associated manic episodes, here are highlights from the week in Psychiatric Times.

The FDA did not grant approval for the treatment for major depressive disorder.

The experts weighed in on a wide variety of psychiatric issues for the July 2023 issue of Psychiatric Times.

"Systemic racism is insidious and ingrained in our daily experience. Women of color are doubly minoritized."

“She would never hurt her baby...”

From a look at adolescent substance use to special challenges in treating borderline personality disorder during the perinatal period, here are highlights from the week in Psychiatric Times.

How does schizophrenia differ between men and women, and what does this mean for developing treatment strategies?

"There is an urgency for competent, thoughtful mental health care for women—not only because the differences have been ignored in the past, but because women’s mental health so often affects health and mental health outcomes for their children."

Black mothers in the US experience far worse outcomes. Here’s what clinicians need to know.

How can BPD traits affect the transition to parenthood?

"Although adolescent substance use is a topic that can be challenging for families and clinicians alike, data demonstrate that interventions during this time are effective for preventing, identifying, and reducing risky use."

Racism is here and happening all around us. One Muslim woman tells her story.

How can you best address and support transgender patients, as well as prevent negative outcomes?

From the FDA traditional approval of Leqembi to an examination of how we can improve mental health care for women of color, here are highlights from the week in Psychiatric Times.

It is essential that clinicians take an active approach in creating a culturally safe space to provide mental health care to WoC.